Further to the TSX Venture Exchange bulletin dated Feb. 19, 2014, effective at the open on Monday, July 6, 2015, the shares of Bradmer Pharmaceuticals Inc. will resume trading, the company having announced the termination of a proposed transaction on June 30, 2015.
© 2024 Canjex Publishing Ltd. All rights reserved.